JCCT 225
The purpose of this study is to look at a study vaccine, called PG4, given with adjuvants, that may be used to extend protection against pneumococcal disease due to a germ called S. pneumoniae.
JCCT 240
The purpose of this study is to evaluate the efficacy and safety of two Covid-19 vaccines, compared to a placebo in adults aged 50 to 64 years who do not have underlying conditions that put them at high risk for severe outcomes from Covid-19.
JCCT 237
This study will evaluate the safety, tolerability, and immunogenicity of VAX-31 and the immunogenicity of SIIV when concomitantly and non-concomitantly administered to adults ≥65 years of age.
JCCT 241
This study will help find out how well the COVID-19 vaccine (BNT162b2) may help protect against COVID-19 in people aged 50-64 years of age who don’t have any serious medical issues that put them at higher risk of severe COVID-19. The study will compare the COVID-19 vaccine to a placebo.
JCCT 229
The purpose of this research is to test a new investigational vaccine VAX-31. We are doing this study to learn about the safety of VAX-31 and whether VAX-31 causes the body to make antibodies (germ‑fighting proteins in the blood).
JCCT 236
The purpose of this research is to test a new investigational vaccine, VAX-31. VAX-31 causes the body to make antibodies (germ fighters) in adults who previously received a pneumococcal vaccine, and potentially increases the amount of antibodies to the strains in common with the previous pneumococcal vaccine.
CRC 010
The purpose of the study is to help to understand how safe, effective, and tolerable different doses of the study treatment QCZ484 are in people living with mild to moderate hypertension.
JCCT 228
This study is testing an investigational drug called GIGA-2339. We want to see if it is safe and easy to handle. We also want to see how your immune system reacts to it, how your body processes it, and what effect it has on your health.
JCCT 243 A
The main purpose of this study is to test an injectable, investigational medication which is being developed to lower the risk of getting COVID.
JCCT 243
The main purpose of this study is to test an injectable, investigational medication which is being developed to lower the risk of getting COVID.
